tetrabenazine has been researched along with Action Tremor in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaud, S; Degos, B; Delion, T; Lapostolle, A; Manceau, P | 1 |
| Albin, RL; Archer, DB; Bohnen, NI; Burciu, RG; Müller, MLTM; Ofori, E; Roy, A; Vaillancourt, DE; Yang, J | 1 |
| Baqi, Y; Barber, J; Correa, M; Lee, CA; Lendent, C; López-Cruz, L; Milligan, M; Müller, CE; Nunes, EJ; Pardo, M; Podurgiel, SJ; Salamone, JD; Thompson, A; Valverde, O; Yohn, SE | 1 |
| Hsiao, IT; Hsieh, CJ; Kung, MP; Lin, KJ; Lin, WY; Lu, CS; Weng, YH; Wey, SP; Yen, TC | 1 |
| Contreras-Mora, HM; Correa, M; Milligan, MN; Podurgiel, SJ; Purcell, LJ; Salamone, JD; Yohn, SE | 1 |
| Correa, M; Dortche, K; Podurgiel, SJ; Salamone, JD; Yohn, SE | 1 |
| Shprecher, D | 1 |
| BUECH, O; KUNZ, HA; MORPURGO, C; STENGER, EG; THEOBALD, W; WILHELMI, G | 1 |
| FUJIWARA, M; SHIMAMOTO, K; YAMAWAKI, T | 1 |
| Anthony, DR; Burns, RH; Ellis, KO; Pelosi, SS; Pong, SF; Wessels, FL; White, RE; White, RL; Wright, GC; Yu, CN | 1 |
| Lloyd, J; Storey, E | 1 |
| Jankovic, J; Stacy, M | 1 |
| Fahn, S; Lees, AJ; Marsden, CD; Meerwaldt, JD; Vecht, CJ | 1 |
| McLellan, DL | 1 |
| Marsden, CD | 1 |
| Dhawan, BN; Singh, HK; Srimal, RC | 1 |
| Baker, WW; Lalley, PM; Rossi, GV | 1 |
| Barry, H; Kubena, RK; Sofia, RD | 1 |
| Jelicić, J | 1 |
| Calne, DB; Webster, RA | 1 |
| Lippmann, W | 1 |
21 other study(ies) available for tetrabenazine and Action Tremor
| Article | Year |
|---|---|
Thrombocytopenia and agranulocytosis in a FXTAS choreic patient treated with tetrabenazine.
Topics: Agranulocytosis; Ataxia; Fragile X Syndrome; Humans; Tetrabenazine; Thrombocytopenia; Tremor | 2021 |
Multimodal dopaminergic and free-water imaging in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Brain; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Tremor; Water | 2019 |
The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Topics: Adrenergic Uptake Inhibitors; Animals; Catalepsy; Data Interpretation, Statistical; Disease Models, Animal; Dose-Response Relationship, Drug; Jaw; Male; Mice; Mice, Knockout; Motor Activity; Movement; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tetrabenazine; Tremor; Vesicular Monoamine Transport Proteins; Xanthines | 2013 |
Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Tremor | 2014 |
Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.
Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Jaw; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tetrabenazine; Tremor | 2015 |
The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Jaw; Male; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Random Allocation; Rats, Sprague-Dawley; Selegiline; Tetrabenazine; Tremor; Vesicular Monoamine Transport Proteins | 2016 |
Sensory trick with metoclopramide-associated tardive tremor.
Topics: Adrenergic Uptake Inhibitors; Aged; Blepharospasm; Cervical Vertebrae; Dopamine Antagonists; Humans; Male; Manipulation, Osteopathic; Metoclopramide; Movement Disorders; Neck; Pressure; Spinal Stenosis; Tetrabenazine; Tremor | 2012 |
[COMPARATIVE PHARMACOLOGICAL INVESTIGATIONS WITH TOFRANIL, PERTOFRAN AND INSIDON].
Topics: Acetylcholine; Amphetamine; Amphetamines; Anesthetics; Animals; Antidepressive Agents; Catatonia; Cats; Chlorpromazine; Cricetinae; Desipramine; Dextroamphetamine; Epinephrine; Ethanol; Guinea Pigs; Hexobarbital; Histamine; Imipramine; Mice; Neuromuscular Junction; Norepinephrine; Opipramol; Orientation; Pharmacology; Rats; Research; Reserpine; Serotonin; Tetrabenazine; Tremor; Tyramine | 1964 |
EFFECTS OF MONOAMINE RELEASERS ON THE TREMOR CONVULSIONS AND LETHAL EFFECTS OF NICOTINE IN MICE.
Topics: Alkaloids; Amines; Dopamine; Hypnotics and Sedatives; Methyldopa; Mice; Nicotine; Pharmacology; Rauwolfia; Research; Reserpine; Seizures; Tetrabenazine; Toxicology; Tremor | 1964 |
5-phenyl-2-furamidines: a new chemical class of potential antidepressants.
Topics: Acetylcholine; Amidines; Animals; Antidepressive Agents; Blepharoptosis; Brain; Furans; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction; Neurotransmitter Agents; Oxotremorine; Rabbits; Rats; Seizures; Synaptosomes; Tetrabenazine; Tremor; Tryptamines | 1983 |
Tardive tremor.
Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Motor Activity; Posture; Rest; Schizophrenia; Tetrabenazine; Tremor | 1997 |
Tardive tremor.
Topics: Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Tetrabenazine; Tremor | 1992 |
What is it? Case 2, 1991: unusual tremor, myoclonus, and a limping gait.
Topics: Adult; Demyelinating Diseases; Diagnosis, Differential; Encephalitis; Gait; Humans; Male; Myoclonus; Neurologic Examination; Psychophysiologic Disorders; Tetrabenazine; Tremor | 1991 |
The suppression of involuntary movements with tetrabenazine.
Topics: Adolescent; Adult; Aged; Ataxia; Athetosis; Depression; Diencephalon; Evaluation Studies as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Tetrabenazine; Time Factors; Tremor | 1972 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor | 1973 |
Experimental evidence for imipramine like activity of fenfluramine.
Topics: Animals; Avoidance Learning; Blepharoptosis; Blood Pressure; Body Temperature; Cats; Columbidae; Drug Antagonism; Drug Synergism; Electroshock; Female; Fenfluramine; Histamine H1 Antagonists; Hypothermia; Imipramine; Male; Mice; Nicotine; Nictitating Membrane; Rabbits; Rats; Reserpine; Respiration; Seizures; Tetrabenazine; Tremor; Tremorine; Vomiting; Yohimbine | 1970 |
Tremor induction by intracaudate injections of bretylium, tetrabenazine, or mescaline: functional deficits in caudate dopamine.
Topics: Acetylcholine; Animals; Bretylium Compounds; Cats; Caudate Nucleus; Dopamine; Electrodes, Implanted; Epinephrine; Hemicholinium 3; Male; Mescaline; Microinjections; Scopolamine; Serotonin; Stereotaxic Techniques; Tetrabenazine; Time Factors; Tremor | 1973 |
Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
Topics: Animals; Antidepressive Agents; Atropine; Behavior, Animal; Body Temperature; Cannabis; Dronabinol; Drug Synergism; Hypothermia, Induced; Imipramine; Male; Mice; Motor Activity; Rats; Reserpine; Salivation; Tetrabenazine; Tremor; Tremorine; Yohimbine | 1973 |
[Experimental contribution to the significance of acetylcholine in the development of static tremor].
Topics: Acetylcholine; Animals; Brain Chemistry; Female; Iproniazid; Male; Rats; Tetrabenazine; Tremor; Tremorine | 1968 |
Tremor induced by tetrabenazine.
Topics: Amobarbital; Animals; Body Temperature; Cats; Disease Models, Animal; Hot Temperature; Parkinson Disease; Scopolamine; Shivering; Sleep; Tetrabenazine; Tremor | 1969 |
Blockade of norepinephrine uptake and related activities of cis- and trans-N,N'-bis-(1-naphthylmethyl)-1,4-cyclohexane bis-(methylamine) dihydrochloride.
Topics: Adipose Tissue; Amines; Animals; Atropine; Chlorpromazine; Cyclohexanes; Desipramine; Drug Antagonism; Epididymis; Eyelids; Female; Hypnotics and Sedatives; Imipramine; Lacrimal Apparatus; Lipid Mobilization; Male; Mathematics; Metaraminol; Methyltyrosines; Mice; Motor Activity; Muscles; Myocardium; Naphthalenes; Norepinephrine; Rats; Species Specificity; Stereoisomerism; Tetrabenazine; Time Factors; Tremor; Tremorine; Tritium | 1970 |